01 February 2023 : Database Analysis
Neutrophil-to-Platelet Ratio in Patients with Ulcerative Colitis Treated with Infliximab or Vedolizumab: A Retrospective, Single-Center Study in Poland
Marcin Warpechowski1CD, Jędrzej Warpechowski2AEF*, Anita Pieńkowska3BEF, Szymon Sagała2BEF, Robert Milewski
4CDE
DOI: 10.12659/MSM.938827
Med Sci Monit 2023; 29:e938827
Figure 7 A receiver operating characteristic curve was used to analyze the predictive ability of the neutrophil-to-platelet ratio during the induction phase (weeks 2, 6, 14) for patients with steroid drugs as concomitant therapy during the induction phase with best cut-off value 33.209. AUC=0.95; 95% CI: 0.806–1; AUC – area under the curve, CI – confidence interval. The figure was created using Statistica version 13 (TIBCO Software, Inc.).